Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Ablative approaches using radioiodine are increasingly proposed for the treatment of Graves′ disease (GD) but their ophthalmologic and biological autoimmune responses remain controversial and data concerning clinical and biochemical outcomes are limited. The aim of this study was to evaluate thyroid...
Saved in:
| Main Authors: | J. Nwatsock, D. Taieb, L. Tessonnier, J. Mancini, F. Dong-A-Zok, O. Mundler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2012-01-01
|
| Series: | World Journal of Nuclear Medicine |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.98731 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of Radioiodine Therapy for Graves' Hyperthyroidism: A Quality-of-Life Assessment
by: Machfud Fauzi, et al.
Published: (2025-07-01) -
Causal association between non-thyroidal autoimmune diseases and Graves' ophthalmopathy: A mendelian randomization study
by: Lan Ma, et al.
Published: (2025-02-01) -
Practical Guidelines Management of Graves Ophthalmopathy
by: Imam Subekti, et al.
Published: (2020-02-01) -
Practical Guidelines Management of Graves Ophthalmopathy
by: Imam Subekti, et al.
Published: (2020-02-01) -
Prevalence of Graves ophthalmopathy among patients with thyroid disease
by: Erwin D. Palisoc, MD, et al.
Published: (2010-06-01)